A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight (TRIUMPH-8)

Phase 3 study (TRIUMPH-8), condition: Obesity, Overweight. The purpose of this study is to evaluate the efficacy and safety of retatrutide compared with placebo for body weight reduction.

Participation in the study will last about 65 weeks and may include about 18 visits. Enrolment: 250 participants. Status: active, not recruiting. No topline or peer-reviewed results are verified for publication on this Record for this study — registry facts only.